Mizuho Securities USA’s Pacira BioSciences PCRX Stock Holding History

Mizuho Securities USA’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,000	Closed	-$261K	–	152
2019 Q2	$261K	Sell	6,000 -18,500	-76%	-$785K	0.01%	127
2019 Q1	$932K	Buy	+24,500	New	+$956K	0.07%	87
2018 Q4	–	Sell	-23,500	Closed	-$1.16M	–	142
2018 Q3	$1.16M	Buy	23,500 +15,500	+194%	+$670K	0.09%	86
2018 Q2	$256K	Sell	8,000 -19,300	-71%	-$666K	0.03%	129
2018 Q1	$850K	Buy	27,300 +18,000	+194%	+$641K	0.05%	81
2017 Q4	$425K	Buy	9,300 +1,600	+21%	+$63.4K	0.02%	137
2017 Q3	$289K	Sell	7,700 -2,000	-21%	-$80.5K	0.01%	163
2017 Q2	$463K	Hold	9,700	–	–	0.02%	117
2017 Q1	$456K	Buy	+9,700	New	+$419K	0.02%	109

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mizuho Securities USA's PCRX Position: Q3 2019 in Review

Mizuho Securities USA sold out of Pacira BioSciences (PCRX) in Q3 2019, closing a stake of 6,000 shares — an estimated $261K sold.

Mizuho Securities USA first reported a position in PCRX in Q1 2017 and held it in 9 quarters. The position peaked at $1.16M in Q3 2018. 211 funds tracked by Wall St. Rank hold PCRX as of Q3 2019.

Mizuho Securities USA reported no remaining Pacira BioSciences position as of Q3 2019 after selling out during the quarter.
Mizuho Securities USA sold 6,000 Pacira BioSciences shares in Q3 2019, an estimated $261K.
Mizuho Securities USA first reported a position in Pacira BioSciences in Q1 2017 and held it in 9 quarters.
Mizuho Securities USA's Pacira BioSciences position peaked at $1.16M in Q3 2018.
211 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2019.

Based on Mizuho Securities USA's 13F filing for Q3 2019, filed 31 Oct 2019.